| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | - | - | - | - | - | - |
| 1 | - | - | - | - | - | - | - | - | - | - | - |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 4.2 |
| 1 | 12.2 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 44.8 |
| 1 | 279.2 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#aMe12 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe22 (R) | Glu | 8 | 2.7 | 23.5% | 23.5% |
| 1 | MeVPLo2 (L) | ACh | 5 | 1.7 | 14.7% | 38.2% |
| 2 | aMe12 (L) | ACh | 3 | 1.0 | 8.8% | 47.1% |
| 3 | DN1a (R) | unclear | 3 | 1.0 | 8.8% | 55.9% |
| instance | NT | total connections | connections /#aMe12 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | 5thsLNv_LNd6 (R) | ACh | 57 | 19.0 | 23.6% | 23.6% |
| 1 | aMe30 (R) | Glu | 23 | 7.7 | 9.5% | 33.1% |
| 2 | LoVC23 (L) | GABA | 22 | 7.3 | 9.1% | 42.1% |
| 3 | aMe22 (R) | Glu | 14 | 4.7 | 5.8% | 47.9% |
| 4 | MeVC21 (R) | Glu | 14 | 4.7 | 5.8% | 53.7% |
| 5 | aMe23 (R) | unclear | 11 | 3.7 | 4.5% | 58.3% |
| 6 | aMe4 (R) | ACh | 9 | 3.0 | 3.7% | 62.0% |
| 7 | l-LNv (R) | unclear | 8 | 2.7 | 3.3% | 65.3% |
| 8 | OA-AL2i3 (R) | OA | 8 | 2.7 | 3.3% | 68.6% |
| 9 | aMe1 (R) | GABA | 7 | 2.3 | 2.9% | 71.5% |
| 10 | aMe25 (R) | unclear | 7 | 2.3 | 2.9% | 74.4% |
| 11 | aMe6c (R) | Glu | 6 | 2.0 | 2.5% | 76.9% |
| 12 | Lat3 (R) | unclear | 5 | 1.7 | 2.1% | 78.9% |
| 13 | MeVPMe7 (R) | Glu | 5 | 1.7 | 2.1% | 81.0% |
| 14 | SLP250 (R) | unclear | 4 | 1.3 | 1.7% | 82.6% |
| 15 | aMe10 (R) | ACh | 3 | 1.0 | 1.2% | 83.9% |
| 16 | aMe12 (L) | ACh | 3 | 1.0 | 1.2% | 85.1% |
| 17 | aMe26 (R) | ACh | 3 | 1.0 | 1.2% | 86.4% |
| 18 | aMe5 (R) | ACh | 3 | 1.0 | 1.2% | 87.6% |
| 19 | aMe_TBD1 (R) | unclear | 3 | 1.0 | 1.2% | 88.8% |
| 20 | MeVC20 (R) | Glu | 3 | 1.0 | 1.2% | 90.1% |
| 21 | MeVPMe12 (R) | ACh | 3 | 1.0 | 1.2% | 91.3% |